Professional Documents
Culture Documents
Internship Report
Internship Report
Submitted by
HEMA.S
Register No: 920221631018
Of
In
OCTOBER 2021
Department of Management studies
INTERNSHIP TRAINING REPORT
AUGUST 2021
This is to certify that the internship training undergone at
HEMA.S
Register No: 920221631018
I HEMA.S affirm that the Internship Training report undergone at BIO TRANS
PHARMACEUTICALS PRIVATE LIMITED, CHENNAI being submitted in partial
fulfillment for the award of Master of Business Administration is the original work carried out
by me. It has not formed the part of any other report submitted for award of any degree or
diploma, either in this or any other University.
PLACE:
ACKNOWLEGEMENT
It is my great feeling of happiness to place on record my deep sense of gratitude to our principal
Dr.A.PUNITHA, for having offering this type of program as a part of this curriculum.
I am very grateful and highly indebted to my guide and Head of Department of Management
Studies, Chettinad College of Engineering and Technology, for his valuable guidance to rendered
during the course of my training Dr.S. Dharmalingam.
I wish to thank my parents and guide for their valuable support during my training.
TABLE OF CONTENTS
1 INTRODUCTION 1
2 FUNCTIONAL DEPARTMENTS 6
3 ANALYSIS - SWOT 25
4 PRODUCT PROFILE 30
5 CONCLUSION 32
ABSTRACT
Internship training is an integral part of MBA program, because it gives us the practical
knowledge of what we have learnt during our study period. But practical knowledge is also
necessary along with the theoretical knowledge. One can see how the theories and knowledge are
being practically implemented. This report is about a pharmaceutical company. This report
carried the information about all departments in the organization and necessary information’s of
the company.
1
1.1 PROFILE OF THE INDUSTRY:
India is the largest provider of generic drugs globally and is known for its
affordable vaccines and generic medications. The Indian Pharmaceutical industry is currently
ranked third in pharmaceutical production by volume after evolving over time into a thriving
industry growing at a CAGR of 9.43% since the past nine years. Generic drugs, over-the-counter
medications, bulk drugs, vaccines, contract research & manufacturing, biosimilars, and biologics
are some of the major segments of the Indian pharma industry. India has the most number of
pharmaceutical manufacturing facilities that are in compliance with the US Food and Drug
Administration (USFDA) and has 500 API producers that make for around 8% of the worldwide
API market.
India is the 12th largest exporter of medical goods in the world. Indian
drugs are exported to more than 200 countries in the world, with US being the key market.
Generic drugs account for 20% of the global export in terms of volume, making the country the
largest provider of generic medicines globally. Indian drug & pharmaceutical exports stood at
US$ 24.60 billion in FY22 and US$ 24.44 billion in FY21. Indian drug & pharmaceutical
exports stood at US$ 2,119.08 million in June 2022.
2
1.2 EVOLUTION OF PHARMACEUTICAL INDUSTRY IN INDIA:
Over the last few decades, the Indian pharmaceutical industry has
experienced rapid expansion, which may be divided into four stages. We can consider the time
before 1970 as the first stage of the pharma industry. At that time, the Indian market was
dominated by foreign companies. The second stage covers 1970 to 1990 when several domestic
companies began operations. 1990 to 2010 is the third stage, where liberalization led Indian
components to launch operations in foreign countries.
The introduction of the patent bill was one of the first advancements in the
pharma industry. The patent bill was proposed for the first time in 1970. The bill allowed the
Indian pharmaceutical sector to become less reliant on intellectual property laws in the United
States.
3
1.3 PHARMACEUTICAL MARKET – AN OVERVIEW:
The evident spread of several major infections and diseases will impact
the global pharmaceutical market with expected growth of $1.3 trillion by 2020. Some of the
trends visible in the pharmaceutical industry include greater pressure on healthcare budget
enforced by rising incidence of chronic diseases; demand for medicines in emerging economies
found more compared to industrialized economies; regulators have become more cautious about
approving new and innovative medicines; rising customer expectations continue to challenge
innovative medicines; increase in new clinically and economically feasible alternative therapies.
The growth in pharmaceutical market is seen in expansion of medical infrastructure; doubling of
disposable incomes among a number of middle-class households; greater penetration of health
insurance; rising prevalence of diseases; aggressive market penetration and adoption of product
patents driven by the relatively smaller companies.
The average human lifespan is exposed to more infections and diseases that require preventive
approaches to maintain health and increased research to improve quality of life among the
population. Hectic daily schedules, lack of exercise and sleep, unhealthy eating habits and other
lifestyle choices has resulted in poor digestion, high obesity rates, breathing difficulties and other
health problems. Globalization and urbanization are major driving forces in the growing demand
for health supplements and improved medications. Rising number of chronic diseases have made
people become more dependent on health supplements and medications. The benefits of
therapies and diagnosis influence pharmaceutical companies towards research and development
to support patients with accurate dose, convenience and compliance to medication regimen with
increase in the incidence of chronic diseases and technological advancements.
4
1.4 PROFILE OF THE COMPANY:
Bio Trans Pharmaceuticals Private Limited is situated at Chennai, Tamil
Nadu is a manufacturer of pharmaceuticals products for more than 3 decades which is classified
as small medium enterprises and is registered under the registrar of companies, Chennai. The
company was established in the year 1989. The company is producing and manufacturing more
than 300 products.
Ramakrishna Meda
Key People Meda Manjula Rao
Meda Malleswara Rao
Age of the company 32 years 8months 26 days
Vendor identification
Communicate and coordinate with vendor audit and at the time of complaint regarding
the material or the product which is manufactured using the material supplied by the
vendor.
6
Purchase departments help keep organizations financially healthy. They
procure goods and services designed to meet operational needs while providing the highest
possible value.
7
2.3.1 BOOK KEEPING:
This is the most basic function of the finance department. It involves the
day-to-day recording, analysis and interpretation of a company’s financial transactions. This will
include the tracking of all expenses (purchases, payments etc.) and sales of finished products. In
some startup companies, this role is often carried out by a bookkeeper who might be replaced by
more specialized payables and receivables clerks as the company grows or expands its
operations.
It is the duty of the finance department to manage all cash flows into and
out of a company and ensure that there are enough funds available to meet the day-to-day
running of the company. This area also encompasses the credit and collections policies for the
company’s customers, to ensure that vendors and creditors are paid correctly and on time; and
that the company is also paid correctly and as when due.
8
2.3.5 MANAGEMENT OF TAXES:
Running a company involves paying tax, and it is the duty of the finance
department to handle tax issues. This includes creating good corporate relationships with
government by remitting PAYE (Pay As You Earn) to the relevant authority, and ensuring that
implementation of tax matters are done within the framed policies.
Apart from analyzing and selecting new investments, it is also the duty of
the finance department to manage company’s existing assets. The finance department should be
concerned with current assets apart from fixed assets. The company’s working capital needs to
be managed efficiently in such a way as to maximize profitability relative to the amount of funds
tied up since it has more implication on the firm liquidity than its fixed asset.
Financial reporting and analysis is the function that takes raw accounting
entries and transforms them into meaningful, usable and comparable financial statements. The
finance department contributes to organizational growth by measuring and reporting on regular
bases, key numbers that are vital to the success of the company. This will likely include a
summary of all funding sources, expenditures and reserves available for future use (excluding
those already committed and budgeted for current period) some non-financial information. And
are usually communicated to managers in a logical and understandable format.
9
2.4 HUMAN RESOURCE DEPARTMENT:
Sampling
10
Specifications
Testing
Documentation
Product release
The basic requirements of quality control are as follows:
(a) Adequate facilities, trained personnel and approved procedures must be available for
sampling, inspecting and testing starting materials, packaging materials, intermediate, bulk, and
finished products, and where appropriate monitoring environmental conditions for GMP
purposes should be done.
(d) Records are made, manually and/or by recording data on-line. This should
demonstrate that all the required sampling, inspecting and testing procedures were actually
carried out. Any deviations from the recommended norms should be recorded and investigated.
(e) The finished products contain active ingredients (a.i.) complying with the qualitative
and quantitative composition, their storage in proper containers must be done. The containers
must be labelled.
(f) Inspection and the date of testing of materials, intermediate, bulk, and finished
products should be formally assessed. The products deviations from specified procedures must
be checked.
(g) No batch of product is released for sale or supply prior to certification by a qualified
person, which is in accordance with the requirements of the marketing authorization.
(h) Sufficient reference samples of starting materials and products are retained to permit
future examination of the product, if necessary. The product is retained in its final pack unless
exceptionally large packs are produced.
11
Once the raw materials enter the factory premises and before going to the stores the
quality of the material will be checked by the quality control department. If they are as per the
guidelines then the QC department approves the raw materials. The finishes product analysis will
be done after the product is manufactured.
The Quality Control department holds the major responsibility as it ensures the quality
and the guidelines that as to be followed while manufacturing the products.
This also includes the control factors and product evaluation before
formation of final product. The system of Quality Assurance for the manufacture of medicinal
12
products should ensure that the products are designed and developed in a way that follows the
requirements of GMP and GLP.
The production and control operations are clearly specified and GMP has
been adopted. The managerial responsibilities must be clearly specified and arrangements made
for the manufacture, supply and use of the starting, and packaging materials should also be taken
care of. All necessary controls or intermediate products, and any other in-process controls and
validations must be carried out.
Equipment qualification
Analyst qualification
Instrument qualification
Process validation
Cleaning validation
Change control
Deviation control
Approval of analytical method validation.
13
2.6 PRODUCTION DEPARTMENT AND ITS CYCLE:
14
The process of drug manufacturing performed in production department in
pharmaceutical unit to series of unit operations. The process may differ from company to
company. At first at the order of requirement by the customers are obtained.
Then the job orders are prepared. Job order is simply an authorization used
in a business to construct goods. A job order typically triggered by the receipt of a customer
order and is then used internally to schedule the work resulting from the customer needs.
The prepared job orders are redirected to the production department and
the checking for the availability of the raw materials take place to ensure that the required raw
materials are available for the production of the demanded goods by the customers and after the
checking of the raw materials the production process commences.
The process carried out by the production department in order to produce a product is depicted
below:
15
2.6.1 BLENDING:
Blending is the first step after the raw material procurement. For drug
blending, to begin with an already developed formulation. Of course, if the formulation has yet
to be developed, they have the commercial equipment and in-house expertise to develop a
formulation for the client. In Pharma industry blending is the vital part to ensure the product
quality. Suring this stage different ingredients are mixed together to form the final blend and the
main purpose of this step is to ensure the adequacy of the mixing of ingredients.
16
2.6.2 DRYING:
17
2.6.3 PUNCHING OF TABLETS:
All tablet press employs the same basic principle of compression. The
basic unit of any tablet press is tooling consisting of two punches and a die called a station. The
upper and lower punches come together in the die that contains the tablet formulation.
Coating is the process by which the tablets are given color and flavor. It
improves the taste, color and odor and ease to the patients to swallow them. Coating is of three
types. They are sugar coating, film coating and enteric coating. Tablet coating is the process
where coating material is applied to the surface of the tablet to achieve the desired properties of
dosage form over the uncoated variety. Various classes of pharmaceutical coating materials used
in tablet coating depending on the phase of coating are reached. Coating materials can be
categorized as follows:
19
2.6.5 CAPSULE FILLING:
21
Aluminum packs are similar to the blister packs but the medicine is not
visible directly, and Strip packs are those in which the tablets are not visible and the embed
design on the packs will not be available.
22
2.7.1 TYPES OF PACKAGING:
Primary Packaging
Tertiary Packaging.
Primary packaging is the material that first envelopes the product and hold
it. This is usually the smallest distribution or use. Example: Aerosol spray cans etc.
23
REPORTING OF GOODS PRODUCED:
After the production of required goods (that is medicines) they are being
reported to the sales department for the shipment of the goods to the concerned clients.
WAREHOUSE (STORES):
Segregation of the material at various stages like Quarantine, under test, approves and
reject.
24
CHAPTER 3
SWOT ANALYSIS
STRENGTHS:
This industry works on so many different levels that it is very hard for
inexperienced personnel to maintain any sub sector of it. So, in order to keep things running
smoothly the industry hires highly trained personnel as its executive officers. This in turn
maintains the high standard that the industry has set for itself.
Skilled staffs:
Any and all staff of the pharmaceutical industry is highly skilled. They are
employed only after they have spent a good amount of time on rigorous training. These staff are
the backbone of this industry. So having a skilled set of staff surely helps with the industry’s face
value.
25
Setting the benchmark:
WEAKNESS:
This industry lacks modern machinery. This makes it rather outdated and
dull as customers are always searching for new and improved health care materials. Not to
mention with modern tech support the production could be a lot faster.
This industry is quite vast and widespread. So, when taking a new and/or
revolutionary decision, it may take a while before it is properly executed. This slows down the
whole process. The main cause is the lengthy decision-making process of the industry. As the
companies have their own board of directors and chairmans they can hardly agree on anything in
a short period.
As the price is quite high for the resources in this sector, profits are quite
low more often than not. And it’s not that it is only the case for some of the companies. Almost
all the companies have low profit margins. This causes the industry to fall behind on the ground
of wealth.
OPPORTUNITIES:
Government support:
This industry is often favored by the government. So, they get all the
support and help they need from the government. It is also the factor for which the industry is
flourishing to this day. The laws and taxes are often in their favor.
Growing space:
This industry is still in its growing phase, according to the Life Cycle of
an Industry. So, it can still go a long way and spread its wings further apart. So, it can still take
control over the market, given the right marketing and advertising.
Financial support:
Along with the government, many insurance companies are also favoring
this industry. They have reasonable conditions and rules for them to follow. Also, the interest
level is very low for them.
Patents:
Global market:
Globalization has made the world closer than ever. This includes all the
customers. The pharmaceutical industry is showing a promising future in the global market. If
this works out well, the deficiency of proper resources and low profit margins will be no more.
27
THREATS:
Currency devaluation:
In the current society’s currency devaluation has taken a turn for the
worse. This is affecting the pharmaceutical industry in a grim manner. It makes the whole ordeal
a lot harder than it already is.
New competitors:
Since globalization, the rivaling industries are increasing. Many people are
interested in the Ayurvedic industry, homeopathic industry and many others instead of
medicines. This poses a great threat to the pharmaceutical industry.
Inflation:
The industry needs to adjust its decision-making process so that it takes less time.
They need to fix their budget so that there is more budget for marketing and research
purposes.
28
They need to be more staff-friendly to keep their morale high.
The board of directors needs to be more engaged.
They also need up the ante in the marketing department.
29
CHAPTER 4
PRODUCT PROFILE
ANTIBIOTICS:
Amlodipine IP.
ANTACIDS:
MULTI VITAMINS:
Monteulastl
30
Levacetitizine Hd IP Tablets.
INJECTIONS:
Salicylates - aspirin.
31
CHAPTER 5
CONCLUSION
32